Acyclovir sodium recalled over sterility concerns
- Recall date
- February 5, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Fresenius Kabi Compounding, LLC recalls acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use B…
- Recall number
- D-0333-2026
- FDA classification
- Class II
- Brand / firm
- Fresenius Kabi Compounding, LLC
- Sold / distributed
- US Nationwide.
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Bag, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-035-56
Get recall alerts
Free email alert whenever Fresenius Kabi Compounding, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Fresenius Kabi Compounding, LLC